Trump wants to do better than the 22% in savings that the Biden administration achieved in the first round, according to a fact sheet distributed by the White House. Trump’s executive order directs ...

The order also directs the Food and Drug Administration to streamline approvals for generic drugs and biosimilars, or copycat versions of complex biologic medications. It also instructs the FDA to ...

The US Food and Drug Administration and Health Canada have issued a warning to change the dose and dosing intervals of famotidine in patients with severe or moderate renal failure. Famotidine, a ...

1997 Glaxo's U.S. patent for ranitidine expires and competitors launch generic alternatives to the drug. 2004-2017 Pfizer receives FDA approval for an over-the-counter version of Zantac in the U.S.

He has complained that neither Mexico nor Canada is doing enough to stop the drug from crossing the border, though significantly more fentanyl crosses into the U.S. through the southern border than ...

Currently in the U.S., there is only one dual GLP-1 and GIP receptor agonist approved by the Food and Drug Administration, which is known as tirzepatide and marketed as Mounjaro.